A detailed history of Canada Pension Plan Investment Board transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 34,100 shares of NBIX stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,100
Previous 50,800 32.87%
Holding current value
$3.9 Million
Previous $5.85 Million 20.42%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$111.62 - $139.44 $1.86 Million - $2.33 Million
-16,700 Reduced 32.87%
34,100 $4.65 Million
Q3 2024

Nov 14, 2024

SELL
$114.58 - $153.15 $1.79 Million - $2.4 Million
-15,649 Reduced 23.55%
50,800 $5.85 Million
Q2 2024

Aug 12, 2024

SELL
$130.86 - $143.19 $16 Million - $17.5 Million
-122,100 Reduced 64.76%
66,449 $9.15 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $16 Million - $17.6 Million
122,649 Added 186.11%
188,549 $26 Million
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $933,415 - $1.17 Million
8,800 Added 15.41%
65,900 $8.68 Million
Q3 2023

Nov 09, 2023

SELL
$94.02 - $117.1 $3.85 Million - $4.79 Million
-40,932 Reduced 41.75%
57,100 $6.42 Million
Q2 2023

Aug 09, 2023

BUY
$89.53 - $104.87 $1.55 Million - $1.82 Million
17,332 Added 21.48%
98,032 $9.24 Million
Q1 2023

May 12, 2023

BUY
$94.11 - $123.02 $1.55 Million - $2.03 Million
16,486 Added 25.67%
80,700 $8.17 Million
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $5.6 Million - $6.67 Million
52,514 Added 448.84%
64,214 $7.67 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $763,849 - $894,823
8,300 Added 244.12%
11,700 $1.24 Million
Q2 2022

Aug 12, 2022

SELL
$75.79 - $100.07 $37,895 - $50,035
-500 Reduced 12.82%
3,400 $331,000
Q1 2022

May 13, 2022

SELL
$72.45 - $94.81 $1.53 Million - $2 Million
-21,100 Reduced 84.4%
3,900 $366,000
Q4 2021

Feb 14, 2022

BUY
$79.65 - $106.22 $1.99 Million - $2.66 Million
25,000 New
25,000 $2.13 Million
Q2 2021

Aug 16, 2021

SELL
$89.43 - $102.27 $1.6 Million - $1.83 Million
-17,855 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $876,312 - $1.19 Million
10,007 Added 127.51%
17,855 $1.74 Million
Q4 2020

Feb 17, 2021

BUY
$86.91 - $108.33 $522,242 - $650,954
6,009 Added 326.75%
7,848 $752,000
Q3 2020

Nov 12, 2020

SELL
$96.16 - $135.15 $1.6 Million - $2.24 Million
-16,611 Reduced 90.03%
1,839 $177,000
Q2 2020

Aug 14, 2020

SELL
$85.09 - $130.36 $278,669 - $426,929
-3,275 Reduced 15.07%
18,450 $2.25 Million
Q1 2020

May 13, 2020

BUY
$75.11 - $113.76 $79,316 - $120,130
1,056 Added 5.11%
21,725 $1.88 Million
Q4 2019

Feb 14, 2020

SELL
$86.8 - $118.57 $419,330 - $572,811
-4,831 Reduced 18.95%
20,669 $2.22 Million
Q3 2019

Nov 12, 2019

SELL
$83.82 - $101.5 $4.61 Million - $5.59 Million
-55,031 Reduced 68.34%
25,500 $2.3 Million
Q2 2019

Aug 12, 2019

BUY
$72.24 - $91.27 $5.82 Million - $7.35 Million
80,531 New
80,531 $6.8 Million
Q4 2017

Feb 14, 2018

SELL
$58.53 - $77.59 $1.13 Million - $1.5 Million
-19,300 Closed
0 $0
Q3 2017

Oct 30, 2017

SELL
$47.97 - $61.28 $259,038 - $330,912
-5,400 Reduced 21.86%
19,300 $1.18 Million
Q2 2017

Jan 31, 2018

BUY
N/A
8,200 Added 49.7%
24,700 $1.14 Million
Q1 2017

Jan 31, 2018

BUY
N/A
16,500
16,500 $714,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $10.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.